Gene name:
FAS (APT1;FAS1;TNFRSF6) ;
Protein name:
Tumor necrosis factor receptor superfamily member 6 ;
Alternative:
Apoptosis-mediating surface antigen FAS ;Apo-1 antigen ;FASLG receptor ;
CD:
CD95 ;
Organism:
Human (Homo sapiens).
General Annotation
Sub Unit:
Binds DAXX. Interacts with HIPK3. Part of a complex containing HIPK3 and FADD (By similarity). Binds RIPK1 and FAIM2. Interacts with BRE and FEM1B. Interacts with FADD.
Function:
Receptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro).
Subcellular Location:
Isoform 6
Secreted
Protein Attributes:
50:
MLGIWTLLPL | VLTSVARLSS | KSVNAQVTDI | NSKGLELRKT | VTTVETQNLE |
100:
GLHHDGQFCH | KPCPPGERKA | RDCTVNGDEP | DCVPCQEGKE | YTDKAHFSSK |
150:
CRRCRLCDEG | HGLEVEINCT | RTQNTKCRCK | PNFFCNSTVC | EHCDPCTKCE |
200:
HGIIKECTLT | SNTKCKEEGS | RSNLGWLCLL | LLPIPLIVWV | KRKEVQKTCR |
250:
KHRKENQGSH | ESPTLNPETV | AINLSDVDLS | KYITTIAGVM | TLSQVKGFVR |
300:
KNGVNEAKID | EIKNDNVQDT | AEQKVQLLRN | WHQLHGKKEA | YDTLIKDLKK |
335:
ANLCTLAEKI | QTIILKDITS | DSENSNFRNE | IQSLV
Vaild Sequence:
Related Databases
Uniprot:
ELISA Kit
CLIA Kit
Polyclonal Antibody
Monoclonal Antibody
Protein
FOR
Human
Mouse
Rat
Pig
Bovine
ELISA Kit for Human Tumor necrosis factor receptor superfamily member 6
ELISA Kit for Human Tumor necrosis factor receptor superfamily member 6
ELISA Kit for Human Tumor necrosis factor receptor superfamily member 6
ELISA Kit for Human Tumor necrosis factor receptor superfamily member 6
ELISA Kit for Human Tumor necrosis factor receptor superfamily member 6
CLIA Kit for Human Tumor necrosis factor receptor superfamily member 6
CLIA Kit for Human Tumor necrosis factor receptor superfamily member 6
CLIA Kit for Human Tumor necrosis factor receptor superfamily member 6
CLIA Kit for Human Tumor necrosis factor receptor superfamily member 6
CLIA Kit for Human Tumor necrosis factor receptor superfamily member 6
Polyclonal Antibody for Human Tumor necrosis factor receptor superfamily member 6
Polyclonal Antibody for Human Tumor necrosis factor receptor superfamily member 6
Polyclonal Antibody for Human Tumor necrosis factor receptor superfamily member 6
Polyclonal Antibody for Human Tumor necrosis factor receptor superfamily member 6
Polyclonal Antibody for Human Tumor necrosis factor receptor superfamily member 6
Monoclonal Antibody for Human Tumor necrosis factor receptor superfamily member 6
Monoclonal Antibody for Human Tumor necrosis factor receptor superfamily member 6
Monoclonal Antibody for Human Tumor necrosis factor receptor superfamily member 6
Monoclonal Antibody for Human Tumor necrosis factor receptor superfamily member 6
Monoclonal Antibody for Human Tumor necrosis factor receptor superfamily member 6
Protein for Human Tumor necrosis factor receptor superfamily member 6
Protein for Human Tumor necrosis factor receptor superfamily member 6
Protein for Human Tumor necrosis factor receptor superfamily member 6
Protein for Human Tumor necrosis factor receptor superfamily member 6
Protein for Human Tumor necrosis factor receptor superfamily member 6
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Precision
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Recovery
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Linearity
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Citations
[1].
M Liu, P Zhang, M Chen, et al.
References
1.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
2.
"Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen."
Oehm A.
,
Behrmann I.
,
Falk W.
,
Pawlita M.
,
Maier G.
,
Klas C.
,
Li-Weber M.
,
Richards S.
,
Dhein J.
,
Trauth B.C.
,
Ponstingl H.
,
Krammer P.H.
J. Biol. Chem.267:10709-10715(1992)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);PROTEIN SEQUENCE OF 226-240; 269-291 AND 321-335
3.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4 AND 6);TISSUE SPECIFICITY
4.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 6);FUNCTION
5.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7)
6.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4 AND 5)
7.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);VARIANT ALPS1A SER-262
8.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)
tissue :
Peripheral blood lymphocyte .
9.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
10.
"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T.
,
Suzuki Y.
,
Nishikawa T.
,
Otsuki T.
,
Sugiyama T.
,
Irie R.
,
Wakamatsu A.
,
Hayashi K.
,
Sato H.
,
Nagai K.
,
Kimura K.
,
Makita H.
,
Sekine M.
,
Obayashi M.
,
Nishi T.
,
Shibahara T.
,
Tanaka T.
,
Ishii S.
,
Yamamoto J.
,
Saito K.
,
Kawai Y.
,
Isono Y.
,
Nakamura Y.
,
Nagahari K.
,
Murakami K.
,
Yasuda T.
,
Iwayanagi T.
,
Wagatsuma M.
,
Shiratori A.
,
Sudo H.
,
Hosoiri T.
,
Kaku Y.
,
Kodaira H.
,
Kondo H.
,
Sugawara M.
,
Takahashi M.
,
Kanda K.
,
Yokoi T.
,
Furuya T.
,
Kikkawa E.
,
Omura Y.
,
Abe K.
,
Kamihara K.
,
Katsuta N.
,
Sato K.
,
Tanikawa M.
,
Yamazaki M.
,
Ninomiya K.
,
Ishibashi T.
,
Yamashita H.
,
Murakawa K.
,
Fujimori K.
,
Tanai H.
,
Kimata M.
,
Watanabe M.
,
Hiraoka S.
,
Chiba Y.
,
Ishida S.
,
Ono Y.
,
Takiguchi S.
,
Watanabe S.
,
Yosida M.
,
Hotuta T.
,
Kusano J.
,
Kanehori K.
,
Takahashi-Fujii A.
,
Hara H.
,
Tanase T.-O.
,
Nomura Y.
,
Togiya S.
,
Komai F.
,
Hara R.
,
Takeuchi K.
,
Arita M.
,
Imose N.
,
Musashino K.
,
Yuuki H.
,
Oshima A.
,
Sasaki N.
,
Aotsuka S.
,
Yoshikawa Y.
,
Matsunawa H.
,
Ichihara T.
,
Shiohata N.
,
Sano S.
,
Moriya S.
,
Momiyama H.
,
Satoh N.
,
Takami S.
,
Terashima Y.
,
Suzuki O.
,
Nakagawa S.
,
Senoh A.
,
Mizoguchi H.
,
Goto Y.
,
Shimizu F.
,
Wakebe H.
,
Hishigaki H.
,
Watanabe T.
,
Sugiyama A.
,
Takemoto M.
,
Kawakami B.
,
Yamazaki M.
,
Watanabe K.
,
Kumagai A.
,
Itakura S.
,
Fukuzumi Y.
,
Fujimori Y.
,
Komiyama M.
,
Tashiro H.
,
Tanigami A.
,
Fujiwara T.
,
Ono T.
,
Yamada K.
,
Fujii Y.
,
Ozaki K.
,
Hirao M.
,
Ohmori Y.
,
Kawabata A.
,
Hikiji T.
,
Kobatake N.
,
Inagaki H.
,
Ikema Y.
,
Okamoto S.
,
Okitani R.
,
Kawakami T.
,
Noguchi S.
,
Itoh T.
,
Shigeta K.
,
Senba T.
,
Matsumura K.
,
Nakajima Y.
,
Mizuno T.
,
Morinaga M.
,
Sasaki M.
,
Togashi T.
,
Oyama M.
,
Hata H.
,
Watanabe M.
,
Komatsu T.
,
Mizushima-Sugano J.
,
Satoh T.
,
Shirai Y.
,
Takahashi Y.
,
Nakagawa K.
,
Okumura K.
,
Nagase T.
,
Nomura N.
,
Kikuchi H.
,
Masuho Y.
,
Yamashita R.
,
Nakai K.
,
Yada T.
,
Nakamura Y.
,
Ohara O.
,
Isogai T.
,
Sugano S.
more...
Nat. Genet.36:40-45(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
11.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANTS THR-16; ILE-122 AND ILE-305
12.
"The DNA sequence and comparative analysis of human chromosome 10."
Deloukas P.
,
Earthrowl M.E.
,
Grafham D.V.
,
Rubenfield M.
,
French L.
,
Steward C.A.
,
Sims S.K.
,
Jones M.C.
,
Searle S.
,
Scott C.
,
Howe K.
,
Hunt S.E.
,
Andrews T.D.
,
Gilbert J.G.R.
,
Swarbreck D.
,
Ashurst J.L.
,
Taylor A.
,
Battles J.
,
Bird C.P.
,
Ainscough R.
,
Almeida J.P.
,
Ashwell R.I.S.
,
Ambrose K.D.
,
Babbage A.K.
,
Bagguley C.L.
,
Bailey J.
,
Banerjee R.
,
Bates K.
,
Beasley H.
,
Bray-Allen S.
,
Brown A.J.
,
Brown J.Y.
,
Burford D.C.
,
Burrill W.
,
Burton J.
,
Cahill P.
,
Camire D.
,
Carter N.P.
,
Chapman J.C.
,
Clark S.Y.
,
Clarke G.
,
Clee C.M.
,
Clegg S.
,
Corby N.
,
Coulson A.
,
Dhami P.
,
Dutta I.
,
Dunn M.
,
Faulkner L.
,
Frankish A.
,
Frankland J.A.
,
Garner P.
,
Garnett J.
,
Gribble S.
,
Griffiths C.
,
Grocock R.
,
Gustafson E.
,
Hammond S.
,
Harley J.L.
,
Hart E.
,
Heath P.D.
,
Ho T.P.
,
Hopkins B.
,
Horne J.
,
Howden P.J.
,
Huckle E.
,
Hynds C.
,
Johnson C.
,
Johnson D.
,
Kana A.
,
Kay M.
,
Kimberley A.M.
,
Kershaw J.K.
,
Kokkinaki M.
,
Laird G.K.
,
Lawlor S.
,
Lee H.M.
,
Leongamornlert D.A.
,
Laird G.
,
Lloyd C.
,
Lloyd D.M.
,
Loveland J.
,
Lovell J.
,
McLaren S.
,
McLay K.E.
,
McMurray A.
,
Mashreghi-Mohammadi M.
,
Matthews L.
,
Milne S.
,
Nickerson T.
,
Nguyen M.
,
Overton-Larty E.
,
Palmer S.A.
,
Pearce A.V.
,
Peck A.I.
,
Pelan S.
,
Phillimore B.
,
Porter K.
,
Rice C.M.
,
Rogosin A.
,
Ross M.T.
,
Sarafidou T.
,
Sehra H.K.
,
Shownkeen R.
,
Skuce C.D.
,
Smith M.
,
Standring L.
,
Sycamore N.
,
Tester J.
,
Thorpe A.
,
Torcasso W.
,
Tracey A.
,
Tromans A.
,
Tsolas J.
,
Wall M.
,
Walsh J.
,
Wang H.
,
Weinstock K.
,
West A.P.
,
Willey D.L.
,
Whitehead S.L.
,
Wilming L.
,
Wray P.W.
,
Young L.
,
Chen Y.
,
Lovering R.C.
,
Moschonas N.K.
,
Siebert R.
,
Fechtel K.
,
Bentley D.
,
Durbin R.M.
,
Hubbard T.
,
Doucette-Stamm L.
,
Beck S.
,
Smith D.R.
,
Rogers J.
more...
Nature429:375-381(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
13.
Mural R.J.
,
Istrail S.
,
Sutton G.G.
,
Florea L.
,
Halpern A.L.
,
Mobarry C.M.
,
Lippert R.
,
Walenz B.
,
Shatkay H.
,
Dew I.
,
Miller J.R.
,
Flanigan M.J.
,
Edwards N.J.
,
Bolanos R.
,
Fasulo D.
,
Halldorsson B.V.
,
Hannenhalli S.
,
Turner R.
,
Yooseph S.
,
Lu F.
,
Nusskern D.R.
,
Shue B.C.
,
Zheng X.H.
,
Zhong F.
,
Delcher A.L.
,
Huson D.H.
,
Kravitz S.A.
,
Mouchard L.
,
Reinert K.
,
Remington K.A.
,
Clark A.G.
,
Waterman M.S.
,
Eichler E.E.
,
Adams M.D.
,
Hunkapiller M.W.
,
Myers E.W.
,
Venter J.C.
more...
Submitted (2005-09) to the EMBL/GenBank/DDBJ databases
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
14.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
tissue :
Urinary bladder .
15.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INTERACTION WITH RIPK1
16.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INTERACTION WITH FEM1B
17.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INTERACTION WITH FAIM2
18.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S)
19.
"A death receptor-associated anti-apoptotic protein, BRE, inhibits mitochondrial apoptotic pathway."
Li Q.
,
Ching A.K.-K.
,
Chan B.C.-L.
,
Chow S.K.-Y.
,
Lim P.-L.
,
Ho T.C.-Y.
,
Ip W.-K.
,
Wong C.-K.
,
Lam C.W.-K.
,
Lee K.K.-H.
,
Chan J.Y.-H.
,
Chui Y.-L.
J. Biol. Chem.279:52106-52116(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INTERACTION WITH BRE
20.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
tissue :
Cervix carcinoma .
21.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-209;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
tissue :
Cervix carcinoma .
22.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-118
tissue :
Liver .
23.
"Whole-exome-sequencing-based discovery of human FADD deficiency."
Bolze A.
,
Byun M.
,
McDonald D.
,
Morgan N.V.
,
Abhyankar A.
,
Premkumar L.
,
Puel A.
,
Bacon C.M.
,
Rieux-Laucat F.
,
Pang K.
,
Britland A.
,
Abel L.
,
Cant A.
,
Maher E.R.
,
Riedl S.J.
,
Hambleton S.
,
Casanova J.L.
Am. J. Hum. Genet.87:873-881(2010)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INTERACTION WITH FADD
24.
"Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
Olsen J.V.
,
Vermeulen M.
,
Santamaria A.
,
Kumar C.
,
Miller M.L.
,
Jensen L.J.
,
Gnad F.
,
Cox J.
,
Jensen T.S.
,
Nigg E.A.
,
Brunak S.
,
Mann M.
Sci. Signal.3:RA3-RA3(2010)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
tissue :
Cervix carcinoma .
25.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
26.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : GLYCOSYLATION AT THR-28;STRUCTURE OF CARBOHYDRATES;IDENTIFICATION BY MASS SPECTROMETRY
27.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : STRUCTURE BY NMR OF 218-335
28.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (2.73 ANGSTROMS) OF 223-335 IN COMPLEX WITH FADD;FUNCTION;SUBUNIT;SUBCELLULAR LOCATION;MUTAGENESIS OF TYR-291 AND ILE-313
29.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT ALPS1A PRO-241
30.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT ALPS1A TYR-260
31.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS ALPS1A TRP-121 AND CYS-232
32.
"Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis."
Sneller M.C.
,
Wang J.
,
Dale J.K.
,
Strober W.
,
Middelton L.A.
,
Choi Y.
,
Fleisher T.A.
,
Lim M.S.
,
Jaffe E.S.
,
Puck J.M.
,
Lenardo M.J.
,
Straus S.E.
Blood89:1341-1348(1997)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS ALPS1A ASP-257 AND SER-310
33.
"Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis."
Pensati L.
,
Costanzo A.
,
Ianni A.
,
Accapezzato D.
,
Iorio R.
,
Natoli G.
,
Nisini R.
,
Almerighi C.
,
Balsano C.
,
Vajro P.
,
Vegnente A.
,
Levrero M.
Gastroenterology113:1384-1389(1997)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT ALPS1A ALA-28
34.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS NON-HODGKIN LYMPHOMA THR-25; PHE-180; LEU-183; ILE-198; VAL-260; LYS-264; LYS-272; PHE-278 AND ASN-299
35.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT ALPS1A VAL-260
36.
"Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance."
Jackson C.E.
,
Fischer R.E.
,
Hsu A.P.
,
Anderson S.M.
,
Choi Y.
,
Wang J.
,
Dale J.K.
,
Fleisher T.A.
,
Middelton L.A.
,
Sneller M.C.
,
Lenardo M.J.
,
Straus S.E.
,
Puck J.M.
Am. J. Hum. Genet.64:1002-1014(1999)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS ALPS1A LYS-241 AND GLN-250
37.
"Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations."
Rieux-Laucat F.
,
Blachere S.
,
Danielan S.
,
De Villartay J.P.
,
Oleastro M.
,
Solary E.
,
Bader-Meunier B.
,
Arkwright P.
,
Pondare C.
,
Bernaudin F.
,
Chapel H.
,
Nielsen S.
,
Berrah M.
,
Fischer A.
,
Le Deist F.
Blood94:2575-2582(1999)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS ALPS1A LEU-249; PRO-250; ASP-253; SER-253; ARG-259; LYS-270 AND LYS-272
38.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT ALPS1A GLY-272
39.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS ALPS1A ARG-82; PRO-250; GLY-260 AND ILE-270
40.
"Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar."
Lee S.H.
,
Shin M.S.
,
Kim H.S.
,
Park W.S.
,
Kim S.Y.
,
Jang J.J.
,
Rhim K.J.
,
Jang J.
,
Lee H.K.
,
Park J.Y.
,
Oh R.R.
,
Han S.Y.
,
Lee J.H.
,
Lee J.Y.
,
Yoo N.J.
J. Invest. Dermatol.114:122-126(2000)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS SQUAMOUS CELL CARCINOMA SER-118; ARG-178 AND ASP-255
41.
"The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis."
Straus S.E.
,
Jaffe E.S.
,
Puck J.M.
,
Dale J.K.
,
Elkon K.B.
,
Roesen-Wolff A.
,
Peters A.M.J.
,
Sneller M.C.
,
Hallahan C.W.
,
Wang J.
,
Fischer R.E.
,
Jackson C.M.
,
Lin A.Y.
,
Baeumler C.
,
Siegert E.
,
Marx A.
,
Vaishnaw A.K.
,
Grodzicky T.
,
Fleisher T.A.
,
Lenardo M.J.
more...
Blood98:194-200(2001)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS ALPS1A PRO-241; VAL-260; ILE-270 AND GLY-272
42.
"The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations."
Wang L.
,
Yang J.K.
,
Kabaleeswaran V.
,
Rice A.J.
,
Cruz A.C.
,
Park A.Y.
,
Yin Q.
,
Damko E.
,
Jang S.B.
,
Raunser S.
,
Robinson C.V.
,
Siegel R.M.
,
Walz T.
,
Wu H.
Nat. Struct. Mol. Biol.17:1324-1329(2010)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : CHARACTERIZATION OF VARIANTS ALPS1A CYS-232; GLN-250; ASP-257; TYR-260; VAL-260; LYS-270 AND LYS-272;MUTAGENESIS OF ARG-250; GLU-261; GLN-283 AND LYS-287